Cleared Traditional

K212977 - SUPER TORQUE MB Angiographic Catheter w...

K212977 is an FDA 510(k) clearance for SUPER TORQUE MB Angiographic Catheter w..., manufactured by Cordis Corporation. The device is a Class 2 Cardiovascular device with product code DQO cleared through the Traditional 510(k) pathway after a 153-day FDA review.

K212977 · Cordis Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2022
Decision
153d
Days
Class 2
Risk

K212977 is an FDA 510(k) clearance for the SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Cordis Corporation (Miami Lakes, US). The FDA issued a Cleared decision on February 17, 2022 after a review of 153 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cordis Corporation devices

FDA 510(k) Submission Details - K212977

510(k) Number K212977 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2021
Decision Date February 17, 2022
Days to Decision 153 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 125d · This submission: 153d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 320
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K212977.
pNOVUS 21 Microcatheter
K221279 · Phenox, Ltd. · Nov 2022
NuCath Wedge Pressure Catheter
K213666 · Pfm Medical, Inc. · Oct 2022
Langston dual lumen catheter
K221470 · Vascular Solutions, LLC · Jun 2022
Progreat Lambda
K211078 · Terumo Clinical Supply Co., Ltd. · Dec 2021
Drakon and Sequre Microcatheters
K203487 · Accurate Medical Therapeutics, Ltd. · Dec 2020
Drakon and Sequre Microcatheters
K202797 · Accurate Medical Therapeutics, Ltd. · Oct 2020